148 related articles for article (PubMed ID: 1799609)
1. [Sensitivity of yeasts of the genus Candida to new antifungal agents].
Hernández-Molina JM; Llosá J; Martínez-Brocal A; de la Rosa M
Enferm Infecc Microbiol Clin; 1991; 9(7):405-8. PubMed ID: 1799609
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
[TBL] [Abstract][Full Text] [Related]
7. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Guinet R
Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
[TBL] [Abstract][Full Text] [Related]
8. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Seifert H; Aurbach U; Stefanik D; Cornely O
Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Lynch ME; Sobel JD
J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
[TBL] [Abstract][Full Text] [Related]
11. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.
Traboulsi RS; Mukherjee PK; Ghannoum MA
Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Candida species strains to five antifungal agents: comparison between agar dilution and disk diffusion tests.
Trancassini M; Ghezzi MC; Cipriani P; Mancini C; Brenciaglia MI
Chemioterapia; 1986 Feb; 5(1):14-7. PubMed ID: 3955776
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.
Szabó Z; Szilágyi J; Tavanti A; Kardos G; Rozgonyi F; Bayegan S; Majoros L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):283-8. PubMed ID: 19394787
[TBL] [Abstract][Full Text] [Related]
15. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of the activity of the preparation cerbiden against Candida spp].
Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of a new automated system for the determination of antifungal sensitivity].
Lozano MC; Parras P; Martín E
Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):135-8. PubMed ID: 8499512
[TBL] [Abstract][Full Text] [Related]
19. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
Rukayadi Y; Lee K; Lee MS; Yong D; Hwang JK
FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
